TRV GP III, LLC
- SEC CIK
- 0001637299
- Latest filing
- Feb 14, 2024
Holdings in Q3 2022
Holdings as of Sep 30, 2022, filed Nov 3, 2022. Long positions only; changes compare share counts with Q2 2022.
- Positions
- 6
- −1 vs. Q2 2022
- Portfolio value
- $229.0M
- −$15.5M (−6.3%) vs. Q2 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PLRXPliant Therapeutics, Inc. | COM | 3,839,160 | $80.2M | 35.0% | −2,000,000−34.3% | Reduced | History |
| RVMDRevolution Medicines, Inc. | COM | 3,604,130 | $71.1M | 31.0% | −1,500,000−29.4% | Reduced | History |
| VYGRVoyager Therapeutics, Inc. | COM | 5,428,933 | $32.1M | 14.0% | −962,243−15.1% | Reduced | History |
| FULCFulcrum Therapeutics, Inc. | COM | 3,962,202 | $32.1M | 14.0% | 00.0% | Unchanged | History |
| DBTXDecibel Therapeutics, Inc. | COM | 3,139,685 | $10.9M | 4.7% | 00.0% | Unchanged | History |
| JNCEJounce Therapeutics, Inc. | COM | 1,148,780 | $2.69M | 1.2% | 00.0% | Unchanged | History |
Sold out since Q2 2022 (1)
Positions held at the end of Q2 2022 that are gone from this filing.